BALCHEM CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.4 USD | +0.91% |
|
+4.01% | +5.16% |
| May. 06 | HC Wainwright Adjusts Balchem Price Target to $170 From $167, Maintains Buy Rating | MT |
| May. 03 | Transcript : Balchem Corporation, Q1 2024 Earnings Call, May 03, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,269 | 3,727 | 5,460 | 3,924 | 4,796 | 5,072 | - |
| Enterprise Value (EV) 1 | 3,269 | 3,727 | 5,460 | 4,298 | 5,041 | 5,196 | 5,045 |
| P/E ratio | 41.5 x | 44.3 x | 57.3 x | 37.6 x | 44.4 x | 40.5 x | 35.8 x |
| Yield | 0.51% | 0.5% | - | - | - | - | - |
| Capitalization / Revenue | 5.08 x | 5.3 x | 6.83 x | 4.16 x | 5.2 x | 5.21 x | 4.93 x |
| EV / Revenue | 5.08 x | 5.3 x | 6.83 x | 4.56 x | 5.46 x | 5.33 x | 4.9 x |
| EV / EBITDA | 20.4 x | 21.4 x | 28.8 x | 21.2 x | 21.8 x | 21.4 x | 19.7 x |
| EV / FCF | 34 x | 32 x | 44.4 x | 48.7 x | 34.6 x | 36.2 x | 29.2 x |
| FCF Yield | 2.94% | 3.13% | 2.25% | 2.05% | 2.89% | 2.76% | 3.42% |
| Price to Book | 4.4 x | 4.52 x | 6.28 x | 4.22 x | 4.58 x | 4.38 x | 3.92 x |
| Nbr of stocks (in thousands) | 32,169 | 32,351 | 32,382 | 32,135 | 32,241 | 32,423 | - |
| Reference price 2 | 101.6 | 115.2 | 168.6 | 122.1 | 148.8 | 156.4 | 156.4 |
| Announcement Date | 2/21/20 | 2/19/21 | 2/18/22 | 2/24/23 | 2/16/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 643.7 | 703.6 | 799 | 942.4 | 922.4 | 974.4 | 1,029 |
| EBITDA 1 | 160 | 174.2 | 189.8 | 202.9 | 230.9 | 242.6 | 256.7 |
| EBIT 1 | 133 | 111.1 | 127.5 | 145.2 | 159.2 | 180.6 | 195.6 |
| Operating Margin | 20.65% | 15.8% | 15.96% | 15.41% | 17.26% | 18.54% | 19.02% |
| Earnings before Tax (EBT) 1 | 96.48 | 106.4 | 125.2 | 133.7 | 137.3 | 163.2 | 185.1 |
| Net income 1 | 79.67 | 84.62 | 96.1 | 105.4 | 108.5 | 126.1 | 142.6 |
| Net margin | 12.38% | 12.03% | 12.03% | 11.18% | 11.77% | 12.94% | 13.86% |
| EPS 2 | 2.450 | 2.600 | 2.940 | 3.250 | 3.350 | 3.863 | 4.367 |
| Free Cash Flow 1 | 96.05 | 116.7 | 123.1 | 88.25 | 145.9 | 143.5 | 172.6 |
| FCF margin | 14.92% | 16.58% | 15.4% | 9.36% | 15.81% | 14.72% | 16.78% |
| FCF Conversion (EBITDA) | 60.02% | 66.95% | 64.83% | 43.5% | 63.17% | 59.12% | 67.22% |
| FCF Conversion (Net income) | 120.56% | 137.87% | 128.05% | 83.75% | 134.39% | 113.73% | 121.04% |
| Dividend per Share | 0.5200 | 0.5800 | - | - | - | - | - |
| Announcement Date | 2/21/20 | 2/19/21 | 2/18/22 | 2/24/23 | 2/16/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 213.1 | 228.9 | 236.7 | 244.3 | 232.5 | 232.5 | 231.3 | 229.9 | 228.7 | 239.7 | 239.2 | 246.9 | 248.6 | 256 | 264 |
| EBITDA 1 | 45.63 | 53.57 | 56.47 | 53.77 | 48.89 | 56.12 | 59.07 | 59.89 | 55.43 | 60.87 | 59.01 | 60.94 | 61.84 | - | - |
| EBIT 1 | 33.82 | 38.34 | 39.92 | 33.62 | 33.3 | 34.41 | 42.84 | 43.61 | 38.34 | 41.68 | 43.89 | 45.54 | 46.61 | - | - |
| Operating Margin | 15.87% | 16.75% | 16.87% | 13.77% | 14.32% | 14.8% | 18.52% | 18.97% | 16.76% | 17.39% | 18.35% | 18.44% | 18.75% | - | - |
| Earnings before Tax (EBT) 1 | 33.15 | 37.63 | 39.26 | 31.08 | 25.78 | 29.12 | 38.4 | 36.48 | 33.27 | 36.85 | 39.08 | 41.39 | 42.93 | - | - |
| Net income 1 | 24.95 | 28.93 | 29.78 | 25.25 | 21.41 | 22.71 | 30.11 | 29.08 | 26.65 | 28.99 | 30.29 | 32.09 | 33.27 | - | - |
| Net margin | 11.71% | 12.64% | 12.58% | 10.34% | 9.21% | 9.77% | 13.02% | 12.64% | 11.65% | 12.09% | 12.66% | 12.99% | 13.38% | - | - |
| EPS 2 | 0.7600 | 0.8900 | 0.9200 | 0.7800 | 0.6600 | 0.7000 | 0.9300 | 0.9000 | 0.8200 | 0.8900 | 0.9233 | 0.9800 | 1.017 | 1.045 | 1.080 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/22 | 4/29/22 | 7/29/22 | 11/4/22 | 2/24/23 | 4/28/23 | 7/28/23 | 10/27/23 | 2/16/24 | 5/3/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 374 | 245 | 124 | - |
| Net Cash position 1 | - | - | - | - | - | - | 27.3 |
| Leverage (Debt/EBITDA) | - | - | - | 1.844 x | 1.062 x | 0.5121 x | - |
| Free Cash Flow 1 | 96 | 117 | 123 | 88.2 | 146 | 143 | 173 |
| ROE (net income / shareholders' equity) | 11.1% | 10.8% | 11.3% | 11.6% | 13% | 12.1% | 12.1% |
| ROA (Net income/ Total Assets) | 7.46% | 7.29% | 8.13% | 7.46% | 8.05% | 8.5% | 9.5% |
| Assets 1 | 1,069 | 1,161 | 1,183 | 1,412 | 1,348 | 1,484 | 1,501 |
| Book Value Per Share 2 | 23.10 | 25.50 | 26.80 | 29.00 | 32.50 | 35.70 | 39.90 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | 28.4 | 33.8 | 37.4 | 50.3 | 37.9 | 40 | 34 |
| Capex / Sales | 4.41% | 4.81% | 4.69% | 5.34% | 4.11% | 4.1% | 3.31% |
| Announcement Date | 2/21/20 | 2/19/21 | 2/18/22 | 2/24/23 | 2/16/24 | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
156.4
USD
Average target price
166
USD
Spread / Average Target
+6.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.16% | 5.07B | |
| +17.73% | 66.69B | |
| +17.77% | 41.24B | |
| +20.17% | 25.89B | |
| +11.75% | 19.81B | |
| +0.85% | 17.11B | |
| -21.87% | 15.86B | |
| +2.72% | 15.35B | |
| -10.29% | 15.23B | |
| -22.30% | 13.36B |
- Stock Market
- Equities
- BCPC Stock
- Financials Balchem Corporation